J&J Buys Up Ambrx for $2B - San Diego Business Journal

Retrieved on: 2024-01-15 19:41:27

Tags for this article:

Click the tags to see associated articles and topics

J&J Buys Up Ambrx for $2B - San Diego Business Journal. View article details on HISWAI: https://www.sdbj.com/life-sciences/jj-buys-up-ambrx-for-2b/

Summary

Ambrx Biopharma Inc., a biotech firm focused on antibody-drug conjugates for cancer treatment, experienced a turnaround from delisting to a $2 billion acquisition by Johnson & Johnson, highlighting the value of biopharma innovation.

Article found on: www.sdbj.com

View Original Article